MedPath

Non-invasive Measuring of Cerebral Perfusion After Severe Brain Injury With Near-infrared-spectroscopy and ICG

Not Applicable
Conditions
Subarachnoid Hemorrhage, Aneurysmal
Intracerebral Hemorrhage (ICH)
Traumatic Brain Injury
Interventions
Procedure: measuring cerebral perfusion by NIRS with ICG
Registration Number
NCT01836848
Lead Sponsor
University of Cologne
Brief Summary

The purpose of this study is to show if it is possible to detect secondary ischemic events in patients with severe brain injury or cerebral haemorrhage with the help of non-invasive near-infrared spectroscopy (NIRS) by using the indocyanine green measuring of cerebral perfusion.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Patients over 18 years
  • onset of clinical symptoms of subarachnoid or intracranial haemorrhage or trauma suffered less than 72h
  • indication for implanting a tissue oxygen and intracranial pressure probe
  • A signed informed consent by the patient or legal guardian
Exclusion Criteria
  • Persistent epidural, subdural or subcutaneous hematoma in planned area of the NIRS optode
  • Open injuries in the area of the planned optodes
  • Malignant primary disease under chemotherapy
  • pregnancy
  • bleeding disorder
  • In the short term unfavorable prognosis (eg, bilateral wide and light-fixed pupils)
  • Patients with pacemakers or where no MRI compatibility is due to non- removable metal parts
  • contraindications for contrast media in CT (eg, iodine allergy)
  • Untreated hyperthyroidism
  • End Stage Renal Disease
  • severe psychomotor agitation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
indocyanine greenmeasuring cerebral perfusion by NIRS with ICGin this arm we do the Intervention 'measuring cerebral perfusion by NIRS with ICG', the pat. gets before a CT-Scan with perfusion measurement a indocyanine green bolus i.v. and a measurement of cerebral perfusion with near-infrared-spectroscopy
Primary Outcome Measures
NameTimeMethod
with near-infrared-spectroscopy detected cerebral perfusion deficit15 days after ictus
Secondary Outcome Measures
NameTimeMethod
Determining a threshold value for cerebral autoregulation measured with near-infrared-spectroscopy as a predictive value for the clinical outcome15 days after ictus and follow up 6 month later

Trial Locations

Locations (1)

Departement of General Neurosurgery of th University of Cologne

🇩🇪

Cologne, Germany

© Copyright 2025. All Rights Reserved by MedPath